MassMutual Private Wealth & Trust FSB cut its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 0.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 290,725 shares of the company's stock after selling 2,755 shares during the quarter. Procter & Gamble makes up about 1.2% of MassMutual Private Wealth & Trust FSB's holdings, making the stock its 15th biggest holding. MassMutual Private Wealth & Trust FSB's holdings in Procter & Gamble were worth $46,318,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Northern Trust Corp grew its position in shares of Procter & Gamble by 0.8% in the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock worth $5,051,930,000 after buying an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after buying an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. grew its position in shares of Procter & Gamble by 3.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock worth $2,966,252,000 after buying an additional 583,629 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Procter & Gamble by 6.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company's stock worth $2,947,146,000 after buying an additional 1,018,865 shares during the period. Finally, Royal Bank of Canada grew its position in shares of Procter & Gamble by 0.6% in the 1st quarter. Royal Bank of Canada now owns 17,273,679 shares of the company's stock worth $2,943,779,000 after buying an additional 111,162 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Procter & Gamble
In other news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the transaction, the chief executive officer owned 34,978 shares in the company, valued at $5,532,120.48. This represents a 22.57% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the transaction, the chief operating officer owned 28,036 shares in the company, valued at $4,409,221.72. This trade represents a 31.74% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is owned by company insiders.
Procter & Gamble Price Performance
PG opened at $156.93 on Tuesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The stock has a market capitalization of $367.30 billion, a P/E ratio of 24.11, a P/E/G ratio of 4.17 and a beta of 0.36. The company's 50-day simple moving average is $156.14 and its two-hundred day simple moving average is $161.65. Procter & Gamble Company has a 52-week low of $149.91 and a 52-week high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a dividend of $1.0568 per share. The ex-dividend date was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble's dividend payout ratio is currently 64.98%.
Analysts Set New Price Targets
PG has been the topic of several recent analyst reports. UBS Group set a $180.00 price objective on shares of Procter & Gamble and gave the company a "buy" rating in a research report on Wednesday, July 30th. Evercore ISI reissued an "in-line" rating and set a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. BNP Paribas reissued an "outperform" rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Barclays set a $164.00 price objective on shares of Procter & Gamble and gave the company an "equal weight" rating in a research report on Thursday, July 31st. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $175.12.
Check Out Our Latest Research Report on Procter & Gamble
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
